Laman UtamaASRT • NASDAQ
add
Assertio Holdings Inc
Tutup sebelumnya
$0.84
Julat hari
$0.80 - $0.84
Julat tahun
$0.74 - $1.80
Permodalan pasaran
76.71J USD
Bilangan Purata
809.48K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 29.20J | -18.03% |
Perbelanjaan pengendalian | 24.40J | -18.13% |
Pendapatan bersih | -2.92J | 98.96% |
Margin untung bersih | -10.00 | 98.73% |
Pendapatan bagi setiap syer | 0.03 | 200.00% |
EBITDA | 3.96J | -56.54% |
Kadar cukai berkesan | -1.53% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 88.58J | 15.21% |
Jumlah aset | 276.00J | -27.37% |
Jumlah liabiliti | 145.48J | -22.27% |
Jumlah ekuiti | 130.52J | — |
Syer tertunggak | 95.48J | — |
Harga kepada buku | 0.61 | — |
Pulangan pada aset | -2.47% | — |
Pulangan pada modal | -4.00% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -2.92J | 98.96% |
Tunai daripada operasi | -35.00K | -101.36% |
Tunai daripada pelaburan | -6.71J | -261.90% |
Tunai daripada pembiayaan | -10.00K | 0.00% |
Perubahan bersih dalam tunai | -6.75J | -200.61% |
Aliran tunai bebas | 900.88K | 99.64% |
Perihal
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration. On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Wikipedia
Diasaskan
1995
Ibu pejabat
Tapak web
Pekerja
53
